Japan
· Delayed Price · Currency is JPY Medikit Statistics
Total Valuation
Medikit has a market cap or net worth of JPY 39.54 billion. The enterprise value is 19.27 billion.
| Market Cap | 39.54B |
| Enterprise Value | 19.27B |
Important Dates
The next estimated earnings date is Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Medikit has 14.62 million shares outstanding. The number of shares has decreased by -11.79% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 14.62M |
| Shares Change (YoY) | -11.79% |
| Shares Change (QoQ) | -0.74% |
| Owned by Insiders (%) | 9.75% |
| Owned by Institutions (%) | 20.57% |
| Float | 5.01M |
Valuation Ratios
The trailing PE ratio is 12.95.
| PE Ratio | 12.95 |
| Forward PE | n/a |
| PS Ratio | 1.79 |
| PB Ratio | 0.90 |
| P/TBV Ratio | 0.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 6.23 |
| EV / Sales | 0.86 |
| EV / EBITDA | 3.05 |
| EV / EBIT | 4.18 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.78
| Current Ratio | 6.78 |
| Quick Ratio | 5.51 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 658.14 |
Financial Efficiency
Return on equity (ROE) is 6.72% and return on invested capital (ROIC) is 6.26%.
| Return on Equity (ROE) | 6.72% |
| Return on Assets (ROA) | 5.53% |
| Return on Invested Capital (ROIC) | 6.26% |
| Return on Capital Employed (ROCE) | 10.16% |
| Revenue Per Employee | 23.12M |
| Profits Per Employee | 3.20M |
| Employee Count | 966 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 3.60 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.71% in the last 52 weeks. The beta is 0.31, so Medikit's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -13.71% |
| 50-Day Moving Average | 2,619.48 |
| 200-Day Moving Average | 2,806.78 |
| Relative Strength Index (RSI) | 65.01 |
| Average Volume (20 Days) | 3,655 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medikit had revenue of JPY 22.33 billion and earned 3.09 billion in profits. Earnings per share was 208.82.
| Revenue | 22.33B |
| Gross Profit | 8.68B |
| Operating Income | 4.61B |
| Pretax Income | 4.66B |
| Net Income | 3.09B |
| EBITDA | 6.32B |
| EBIT | 4.61B |
| Earnings Per Share (EPS) | 208.82 |
Balance Sheet
The company has 20.27 billion in cash and n/a in debt, giving a net cash position of 20.27 billion or 1,386.40 per share.
| Cash & Cash Equivalents | 20.27B |
| Total Debt | n/a |
| Net Cash | 20.27B |
| Net Cash Per Share | 1,386.40 |
| Equity (Book Value) | 44.16B |
| Book Value Per Share | 3,020.11 |
| Working Capital | 27.24B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 38.85%, with operating and profit margins of 20.63% and 13.85%.
| Gross Margin | 38.85% |
| Operating Margin | 20.63% |
| Pretax Margin | 20.87% |
| Profit Margin | 13.85% |
| EBITDA Margin | 28.29% |
| EBIT Margin | 20.63% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 90.00, which amounts to a dividend yield of 3.33%.
| Dividend Per Share | 90.00 |
| Dividend Yield | 3.33% |
| Dividend Growth (YoY) | 12.50% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 11.79% |
| Shareholder Yield | 15.12% |
| Earnings Yield | 7.82% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on March 30, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Mar 30, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Medikit has an Altman Z-Score of 7.16.
| Altman Z-Score | 7.16 |
| Piotroski F-Score | n/a |